S Manoj Kumar Kingsley1, B Vishnu Bhat2. 1. Department of Neonatology, Jawaharlal Institute of Post Graduate Medical Education and Research (JIPMER), Puducherry, 605006, India. 2. Department of Neonatology, Jawaharlal Institute of Post Graduate Medical Education and Research (JIPMER), Puducherry, 605006, India. drvishnubhat@yahoo.com.
Abstract
INTRODUCTION: MicroRNAs have been found to be of high significance in the regulation of various genes and processes in the body. Sepsis is a serious clinical problem which arises due to the excessive host inflammatory response to infection. The non-specific clinical features and delayed diagnosis of sepsis has been a matter of concern for long time. FINDINGS: MicroRNAs could enable better diagnosis of sepsis and help in the identification of the various stages of sepsis. Improved diagnosis may enable quicker and more effective treatment measures. The initial acute and transient phase of sepsis involves excessive secretion of pro-inflammatory cytokines which causes severe damage. MicroRNAs negatively regulate the toll-like receptor signaling pathway and regulate the production of inflammatory cytokines during sepsis. Likewise, microRNAs have shown to regulate the vascular barrier and endothelial function in sepsis. They are also involved in the regulation of the apoptosis, immunosuppression, and organ dysfunction in later stages of sepsis. Their importance at various levels of the pathophysiology of sepsis has been discussed along with the challenges and future perspectives. CONCLUSION: MicroRNAs could be key players in the diagnosis and staging of sepsis. Their regulation at various stages of sepsis suggests that they may have an important role in altering the outcome associated with sepsis.
INTRODUCTION: MicroRNAs have been found to be of high significance in the regulation of various genes and processes in the body. Sepsis is a serious clinical problem which arises due to the excessive host inflammatory response to infection. The non-specific clinical features and delayed diagnosis of sepsis has been a matter of concern for long time. FINDINGS: MicroRNAs could enable better diagnosis of sepsis and help in the identification of the various stages of sepsis. Improved diagnosis may enable quicker and more effective treatment measures. The initial acute and transient phase of sepsis involves excessive secretion of pro-inflammatory cytokines which causes severe damage. MicroRNAs negatively regulate the toll-like receptor signaling pathway and regulate the production of inflammatory cytokines during sepsis. Likewise, microRNAs have shown to regulate the vascular barrier and endothelial function in sepsis. They are also involved in the regulation of the apoptosis, immunosuppression, and organ dysfunction in later stages of sepsis. Their importance at various levels of the pathophysiology of sepsis has been discussed along with the challenges and future perspectives. CONCLUSION: MicroRNAs could be key players in the diagnosis and staging of sepsis. Their regulation at various stages of sepsis suggests that they may have an important role in altering the outcome associated with sepsis.
Entities:
Keywords:
Immunosuppression; Inflammatory cytokines; Inflammatory response; MicroRNAs; Organ dysfunction; Sepsis
Authors: Frank Hildebrand; Hans-Christoph Pape; Paul Harwood; Katrin Müller; Petra Hoevel; Claudia Pütz; Arne Siemann; Christian Krettek; Martijn van Griensven Journal: Exp Toxicol Pathol Date: 2005-03
Authors: Kuniaki Ejima; Matthew D Layne; Irvith M Carvajal; Patricia A Kritek; Rebecca M Baron; Yen-Hsu Chen; Jeffrey Vom Saal; Bruce D Levy; Shaw-Fang Yet; Mark A Perrella Journal: FASEB J Date: 2003-05-08 Impact factor: 5.191
Authors: Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill Journal: Nat Immunol Date: 2009-11-29 Impact factor: 25.606
Authors: David F Gaieski; Mark E Mikkelsen; Roger A Band; Jesse M Pines; Richard Massone; Frances F Furia; Frances S Shofer; Munish Goyal Journal: Crit Care Med Date: 2010-04 Impact factor: 7.598
Authors: Victor Chatterjee; Richard S Beard; Jason J Reynolds; Ricci Haines; Mingzhang Guo; Matthew Rubin; Jenny Guido; Mack H Wu; Sarah Y Yuan Journal: PLoS One Date: 2014-10-15 Impact factor: 3.240
Authors: Yan Wu; Pengfei Li; Andrew J Goodwin; James A Cook; Perry V Halushka; Basilia Zingarelli; Hongkuan Fan Journal: J Infect Dis Date: 2020-08-17 Impact factor: 5.226
Authors: Jesús Beltrán-García; Rebeca Osca-Verdegal; Elena Nacher-Sendra; Federico V Pallardó; José Luis García-Giménez Journal: Cells Date: 2020-06-25 Impact factor: 6.600
Authors: P Möhnle; S Hirschberger; L C Hinske; J Briegel; M Hübner; S Weis; G Dimopoulos; M Bauer; E J Giamarellos-Bourboulis; S Kreth Journal: Mol Med Date: 2018-10-17 Impact factor: 6.354